Vice President, Cain Brothers

Eugene Goldenberg is a Vice President in the Firm’s Corporate M&A Advisory practice. Mr. Goldenberg joined Cain Brothers in 2012 with over 6 years’ healthcare services equity research experience covering many of the same sector verticals where he now utilizes his advisory and deal execution capabilities. Mr. Goldenberg’s recent notable transactions include a private placement by Coliseum Capital on behalf of BioScrip, the sale of Salveo Specialty Pharmacy to Catamaran, LASIK Vision Institute’s acquisition of TLC Laser Eye Centers, the sale of LCA-Vision to PhotoMedex, and the sale of BioScrip’s Home Health Services Business to LHC Group. Prior to joining Cain Brothers, Mr. Goldenberg was a Senior Equity Research Analyst at BB&T Capital Markets, where he focused on various healthcare services verticals, including Post-Acute Care (Home Health, Hospice, Skilled Nursing Facilities, and Long-Term Acute Care Hospitals), as well as Pharmacy Benefit Managers, Specialty Supplies Distribution, Community-Based Services, Specialty Pharmacy, Home Infusion, Healthcare IT, and Wellness / Disease Management. Mr. Goldenberg’s prior experience also includes working within Morgan Stanley’s Controller Financial Reporting group.